08.03.2014 Views

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

When citing these abstracts please use the following reference:<br />

Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number.<br />

Please note that the official publication of the <strong>International</strong> Journal of <strong>Infectious</strong> Diseases 2010, Volume 14, Supplement 1<br />

is available electronically on http://www.sciencedirect.com<br />

Final Abstract Number: 82.002<br />

Session: Trypanosomiasis, Leishmaniasis & Schistosomiasis<br />

Date: Friday, March 12, 2010<br />

Time: 12:30-13:30<br />

Room: <strong>Poster</strong> & Exhibition Area/Ground Level<br />

Type: <strong>Poster</strong> Presentation<br />

A diagnostic approach to detect murine Shistosoma mansoni infection using a polymerase chain<br />

reaction<br />

A. Hassan<br />

Faculty of Health Sciences, Gizan University, Gizan, Gizan, Saudi Arabia<br />

Background: Traditional diagnosis of Schistosoma mansoni infection involves direct microscopic<br />

detection of eggs in feces. The use of some stool concentration techniques may increase the<br />

diagnostic yield. However, it seems that the sensitivity of parasitological methods diminishes<br />

when prevalence and intensity of infection are low, making these methods less appropriate <strong>for</strong><br />

low-endemic areas and in post treatment situations.<br />

In 2001, a new antischistosomal drug, Mirazid® was introduced into the Egyptian market by<br />

Pharco Pharmaceutical Company (Alexandria, Egypt). Extensive advertising ef<strong>for</strong>ts have<br />

encouraged physicians in private clinics to use Mirazid. The chemistry of myrrh is not fully<br />

studied. Reports on its anti-schistosomal effect in human or experimental animals seem to be<br />

controversial.<br />

Methods: Our present study is a laboratory trial aimed at using conventional PCR technique <strong>for</strong><br />

studying the schistosomicidal effect of Mirazid® in the murine model, and comparing the results<br />

with the parasitological results (ova and worm count).<br />

Results: Microscopic results showed that there was no eggs passing till the 41st day of<br />

infection by examining fecal samples of all infected mice by Kato-Katz technique. Only on the<br />

42nd day, the first batch of eggs appeared in stool samples. Comparable results were found in<br />

the number of S. mansoni worms recovered from sacrificed mice of infected groups.<br />

By using PCR <strong>for</strong> detection of S. mansoni specific DNA sequences in murine fecal samples of<br />

infected control group, all fecal samples showed positive results by using feces from the 45th day<br />

after infection. On the other hand, all fecal samples of uninfected control group showed negative<br />

results.<br />

Regarding results of the Mirazid® treated group, six fecal samples (60%) showed positive results<br />

<strong>for</strong> feces from the 77th day after infection. Interestingly, the four mice diagnosed negative by PCR<br />

were among the eight mice that diagnosed negative by the microscopic technique.<br />

Conclusion: The used PCR technique was more sensitive than the Kato-Katz thick smears.<br />

Mirazid® showed some schistosomicidal effects against murine S. mansoni. However, it was not<br />

efficient enough to cure any of the mice. Thus, re-evaluation of myrrh as a schistosomicidal drug<br />

must be considered because of its recommendation by some Egyptian physicians motivated by<br />

its natural origin.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!